Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose

Overview of attention for article published in Journal of Translational Medicine, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 3 news outlets

twitter: 4 X users

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 40 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Cancer-killing virus injected into human for the first time

awsforwp, 02 Jun 2022

A recent clinical trial has started evaluating the safety and tolerability of a novel therapy involving a virus that can infect…

Cancer-killing virus injected into human for the first time - daytonews

Day To News.com, 02 Jun 2022

A recent clinical trial has begun evaluating the safety and tolerability of a new therapy using a virus that can infect and…

Cancer-killing virus injected into human for the first time in new…

Medical News Today, 02 Jun 2022

A recent clinical trial has started evaluating the safety and tolerability of a novel therapy involving a virus that can infect…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.